For instance, immune checkpoint inhibitors include antibodies targeting PD-1, PD-L1), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) loaded in EVs and can stimulate an immune response, leading to the targeted elimination of cancer cells [234,235]. This evidence concerns the gene CTLA4 and cancer.